The United
States PCOS Treatment Market is expected to grow at an impressive rate during
the forecast period, 2024-2028 owing to advancements in medical research, and healthcare policies. The rising prevalence and
diagnosis of PCOS are the main factors propelling the market for its treatment
in the United States. Campaigns for public awareness of PCOS have made
significant progress over the past years, as have initiatives for education and
media coverage. As a result of more women seeking medical attention for their
symptoms, there are currently more cases being diagnosed. The market for PCOS
treatments is expanding as a result of the increased need for effective
treatment alternatives.
The early and
precise diagnosis of PCOS has been made possible due to advancements in medical
technology. Transvaginal ultrasonography, hormone testing, and other
innovations have made it easier for medical professionals to identify the
disease.. These developments allow for prompt intervention and individualized
treatment strategies, improving patient outcomes. The advent of more accurate
diagnostic technologies has improved the reliability of PCOS diagnosis and
helped fuel the expansion of the treatment industry.
Ongoing
research and development activities in the field have made novel treatments for
PCOS possible. Drugs that target the underlying hormonal imbalances and
symptoms linked to PCOS are being actively developed in clinical trials by
pharmaceutical companies and academic institutions. Additionally, partnerships
between companies, governments, and academic institutions have quickened the
speed of invention. These innovations have increased the variety of treatment
options accessible and stimulated market expansion.
Personalized
medicine is becoming more popular as a result of developments in genetics and
molecular biology, and PCOS treatment is no exception. Healthcare professionals
can create treatment strategies that are personalized for each patient by
understanding the distinct genetic and metabolic components that contribute to
PCOS in each person. Precision therapeutics are being developed to enhance
treatment outcomes and reduce adverse effects, such as targeted drugs and
hormone therapy. As patients seek more individualized and effective treatments,
this personalized approach to PCOS treatment is likely to drive market
expansion.
In recent
years, there has been an increasing emphasis on patient-centered care, with a
focus on individualized treatment programs catered to specific patient needs.
This method strives to address each patient's particular issues and
acknowledges the diversity of PCOS symptoms. In order to provide comprehensive
care, healthcare providers are increasingly using a multidisciplinary strategy
that includes endocrinologists, gynecologists, dieticians, and mental health
specialists. The market for PCOS treatments has grown favorably as a result of
the trend towards patient-centered care, which has raised demand for a wider
variety of treatment alternatives.
The healthcare sector is changing as a result of digital health
solutions like smartphone apps, wearable technology, and telemedicine
platforms. These tools are being used more frequently in PCOS treatment to help
patients better manage their condition, keep track of their symptoms, and
communicate with their doctors. Mobile apps enable patients to actively
participate in their treatment process by offering features like symptom
tracking, dietary advice, and activity programs. Platforms for telemedicine
allow for remote consultations, lowering access challenges and improving
patient comfort. By enhancing patient involvement, adherence, and overall
treatment outcomes, the integration of digital health solutions will contribute
to market expansion.
For women
with PCOS, infertility is a big concern. The market is expanding as a
consequence of the rising demand for fertility treatments and assisted
reproductive technologies (ART). To enhance results for PCOS patients, in vitro
fertilization (IVF), ovulation induction drugs, and other reproductive
procedures are being improved. In the upcoming years, the market for PCOS
treatments is expected to be significantly impacted by the focus on fertility
and reproductive health.
While there are
development prospects for the PCOS treatment market in the United States, there
are also specific challenges that will limit that industry's growth. These
challenges include inadequate attention to mental health, inaccurate diagnosis,
a lack of ideal treatment alternatives, cost and affordability issues, a lack
of adequate research, and problems with patient adherence.
PCOS has a
significant impact on both mental and emotional health along with physical
health. Women with PCOS often deal with depression, anxiety, body image
difficulties, and low self-esteem. However, PCOS treatment regimens sometimes
place too little emphasis on counselling and support services for mental
health. By making it more difficult for PCOS patients to access holistic and
comprehensive medical attention, neglecting mental health factors can restrict
the expansion of the treatment market.
Treatment for
PCOS usually involves long-term management techniques that call for changes in
diet, consistent consumption of drugs, and on-going evaluation. However, a
number of challenges, such as treatment complexity, side effects, and a lack of
support, can make it difficult for patients to stick to treatment plans. Poor
adherence might reduce patient satisfaction and lower demand for PCOS treatments,
which can have a detrimental effect on treatment outcomes and market growth.
Download Free Sample Report
Rising
Prevalence and Diagnosis of PCOS
The increased
incidence and diagnosis of PCOS in the United States is expected to have a
substantial impact on the expansion of the PCOS treatment market in the
coming years. Among women of reproductive age, PCOS is one of the hormonal
conditions with the highest prevalence and has been rising over time. Numerous
factors, such as inactive habits, lifestyle adjustments, and rising obesity
rates, can be attributed to this increased trend. There is a rising need for
efficient treatment alternatives to control PCOS symptoms and enhance quality
of life as more and more people are receiving the diagnosis.
PCOS affects
6% to 12% (up to 5 million) of United States women of reproductive age,
making it one of the most prevalent causes of female infertility, according to
the CDC (Centers for Disease Control and Prevention).
The growing
awareness and recognition of PCOS has culminated in better diagnostic
techniques and recommendations, which have led to quicker and more accurate
diagnosis. The adoption of suitable treatment plans and early action are made
possible by this early detection. Consequently, healthcare professionals are
better prepared to address the unique requirements of PCOS patients, resulting
in improved treatment outcomes.
Advancements in
Medical Research
The future
expansion of the PCOS treatment market in the United States will likely be
significantly influenced by developments in medical research. The development
of new therapies and the expansion of treatment options are being sparked by
continuing research efforts as the understanding of PCOS advances.
Researchers can find new pharmacological targets and therapeutic strategies by
addressing the complex mechanisms and underlying causes of PCOS. This study
focuses on addressing the fundamental hormonal imbalances and metabolic
dysfunctions linked to PCOS in along with treating the condition's symptoms.
Precision
medicine techniques that are suited to the demands of specific individuals are
becoming more feasible as medical research advances. Genetic research is
shedding a glimpse on the distinctive genetic variations and gene expression
patterns associated with PCOS, paving up opportunities to targeted treatments.
In order to help PCOS patients regain hormonal balance, new developments in
hormone regulation and modulation are also being researched. Such discoveries
could fundamentally alter treatment plans and vastly improve interventional
effectiveness.
Medical
research has a significant impact on the development of non-pharmacological
therapies and lifestyle management measures for PCOS in addition to therapeutic
advancements. Studies looking into how dietary changes, exercise routines, and
behavioral interventions affect PCOS symptoms and metabolic health.
Market Segmentation
The United States PCOS
Treatment Market can be segmented by surgery, drug,
diagnosis, end user, region and competitive landscape. By surgery, the United States PCOS
Treatment Market can be segmented into Ovarian Wedge Resection, Cyst
Aspiration, and Laparoscopic Ovarian Drilling. Based on drug, the United States
PCOS Treatment Market is divided into Ovulation Inducing Agents,
Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens,
Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, and Others.
Based on Diagnosis, the United States PCOS Treatment Market is divided into Pelvic
Examination, Ultrasound, and Blood Tests. Based on End User, the market is
divided into Hospitals & Clinics, Ambulatory Surgical Centers, and Fertility
Clinics.
Market Players
Myovant Sciences, AbbVie Inc., AstraZeneca
PLC, Bayer AG, Ferring Pharmaceuticals, Theralogix are among others some of the
leading companies operating in the market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 –
2021
|
|
Estimated Year
|
2023
|
|
Forecast Period
|
2024
– 2028
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
|
|
Report coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments covered
|
By Surgery
By Drug
By Diagnosis
By End User
|
|
Regional scope
|
Northeast Region; Midwest Region; South Region; West Region
|
|
Key companies profiled
|
Myovant Sciences, AbbVie Inc., AstraZeneca PLC, Bayer AG,
Ferring Pharmaceuticals, Theralogix
|
|
Customization scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can also
provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, United States PCOS
Treatment Market has been segmented into following categories, in addition to
the industry trends which have also been detailed below:
·
United States PCOS Treatment Market, By Surgery
o
Ovarian Wedge Resection
o
Cyst Aspiration
o
Laparoscopic Ovarian Drilling
·
United States PCOS Treatment Market, By
Drug
o Ovulation
Inducing Agents
o Insulin-Sensitizing
Agents
o Oral
Contraceptives
o Antiandrogens
o Anti-Depressants
o Insulin-Sensitizing
Agents
o Anti-Obesity
Drugs
o Others
·
United States PCOS Treatment Market, By Diagnosis
o Pelvic
Examination
o Ultrasound
o Blood
Tests
·
United States PCOS Treatment Market, By End User
o Hospitals
& Clinics
o Ambulatory
Surgical Centers
o Fertility
Clinics
Competitive Landscape
Company Profiles: Detailed analysis of the major
companies present in the United States PCOS Treatment Market
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company
Information
Detailed analysis and
profiling of additional market players (up to five)